Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
MastekQ1 FY27IT - Software
Home/Stocks/Mastek/Q1 FY27

Mastek Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,665P/E: 12.1Market Cap: ₹5.3K CrSector: IT - Software

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • →U.K. business expected to continue delivering good growth and momentum.
  • →North America business has positive order book tailwinds; expected to turn into a growth engine by H2 FY27 after 1-2 more quarters of ramp-up.
  • →FY27 performance anticipated to be better than FY26, driven by order backlog and new deal pipeline.
  • →Middle East business faces uncertainty due to geopolitical turmoil; growth depends on stabilization but has a strong pipeline.
  • →AI-led initiatives driving new opportunities in existing and net new accounts across geographies.
  • →Healthcare vertical in U.K. and U.S. expected to ramp up strongly from Q2 and especially H2.
  • →Overall demand environment is positive with good traction in order books and increasing large deal pipeline.
  • →Margin improvements expected with better execution, cost efficiencies, and business shaping.

Margin guidance

Category 3
  • →Mastek expects steady revenue growth driven by strong order book and AI-led initiatives, particularly in Healthcare and public sector verticals.
  • →North America business is anticipated to ramp up, with mid-teens margins targeted at $28-$30 million quarterly run rate.
  • →Middle East business faces near-term uncertainties but is expected to stabilize with potential growth if geopolitical conditions improve.
  • →EBITDA margins impacted in short term by ESOP costs (estimated $400K-$500K per quarter) and planned salary increments in Q2, but internal cost efficiencies are in progress to mitigate effects.
  • →Long-term steady-state EBITDA margins are expected to improve due to leadership stability and improved operational execution.
  • →Earnings per share (EPS) showed 14.8%-15% YoY growth in Q1, indicating positive earnings momentum.
  • →Positive operating cash flow and prudent cash management underpin financial strength supporting growth initiatives.

3 more insights locked — sign up free to unlock

Fundraise plans

  • →No explicit mention of current or future fundraising through debt or equity in the transcript.
  • →The company reports improved cash and investment position by almost INR 200 crore over the last two quarters due to prudent cash management and aggressive collections.
  • →Positive operating cash flow of nearly INR 27 crore reported in Q1FY27.
  • →No guidance or plans shared about raising funds via debt or equity during the call.
  • →Focus appears to be on internal transformations, AI-led growth, and business expansion rather than external fundraising.

Order book

Yes
  • →The 12-month order backlog has grown by 25% year-on-year and 13% in constant currency terms, indicating strong order book momentum.
  • →The total contract value (TCV) is healthy and moving positively, exemplified by a recent $25 million, 5-year deal in North America.
  • →There is a good increase in the number of large deal pipeline items across geographies.
  • →The AI-led opportunities in the order pipeline are increasing consistently, with multiple ongoing campaigns in existing and new customers.
  • →Middle East has a strong order pipe, including large Healthcare deals close to signature and ramp-up, although political volatility creates some uncertainty.
  • →North America shows good order book growth and is expected to turn into a growth engine by H2FY27 as current projects ramp down and new deals ramp up.
  • →U.K. business order book remains strong, supporting solid revenue growth.

Capex plans

Yes
  • →Mastek is undergoing a significant AI-led business transformation internally, treating itself as "Customer Zero."
  • →Investments include replacing core systems of records (CRM, recruitment, payables) with AI-native, system-of-intelligence solutions.
  • →Focus on transforming from an engineering powerhouse to a transformation powerhouse, including upskilling resources to Forward Deployed Engineers (FDEs) and Forward Deployed Domain Consultants (FDDCs).
  • →AI transformation is not only client-facing but is being executed internally as a strategic investment.
  • →Investment in transforming resources from traditional engineering roles to forward deployed roles is a key strategic change.
  • →These internal transformations aim to deliver improved business outcomes such as recruitment efficiency, win predictability, and cost efficiencies.
  • →No explicit mention of traditional capital expenditures but strategic investments are centered on AI, software transformation, and human capital development.

How does Mastek rank vs peers in IT - Software?

Pro feature
1Mastek
Rev 3Mar 3
2IT - Software Company A
Rev 1Mar 2
3IT - Software Company B
Rev 2Mar 1
4IT - Software Company C
Rev 2Mar 3

See full IT - Software sector rankings

How does Mastek rank in IT - Software?

Compare Mastek against every IT - Software company (Q1 FY27) on revenue, margins and earnings-call signals.

View IT - Software leaderboard →

Related research

Read the full Q1 FY27 earnings insight — Mastek

Other quarters — Mastek

Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24

IT - Software peers

HCL Technologies Ltd · Q1 FY27Hexaware Technologies Ltd · Q4 FY26Infosys · Q1 FY27Mphasis · Q1 FY27Coforge · Q1 FY27
Mastek full stock analysisIT - Software sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What Mastek's management said in earlier quarters

  • Q1 FY27 earnings call analysis →
  • Q2 FY26 earnings call analysis →
  • Q4 FY26 earnings call analysis →
  • Q4 FY25 earnings call analysis →

Others in IT - Software this season

  • All E Technologies Ltd (Q1 FY27)

    Overall, a 9.1% YoY revenue growth in the latest quarter signals a return to growth trajectory. Key concall takeaways from All E Technologies Ltd's Q1 FY27…

  • Mphasis (Q1 FY27)

    63% of Q1 TCV wins were AI-led, indicating strong growth in AI-driven deals. Key concall takeaways from Mphasis's Q1 FY27 earnings call — and how it ranks…

  • Persistent Systems (Q1 FY27)

    Overall confidence in continuing Persistent's ~17-24% CAGR growth trajectory with expanded scale (Pages 5-6). Key concall takeaways from Persistent Systems's…

  • Birlasoft Ltd (Q1 FY27)

    Q1 is traditionally a weak quarter for deal signings; however, Q1 FY27 deal signings showed a 20% growth compared to last year. Key concall takeaways from…

Compare:vs TCSvs Infosysvs HCL Technologies Ltd